Exact Mass: 300.16

p-(1-Methyl-2,2-diphenylvinyl)anisole

C22H20O (300.1514)

Azapropazone

C16H20N4O2 (300.1586)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

Calindol

C21H20N2 (300.1626)

Metaphit

C18H24N2S (300.166)

5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N'-propylpentanehydrazide

C13H24N4O2S (300.162)

Strobilol C

C15H24O6 (300.1573)

Ficusolide diacetate

C15H24O6 (300.1573)

Cycloparvifloralone

C15H24O6 (300.1573)

Debenzoyldunnianin

C15H24O6 (300.1573)

Dendronobilin M

C15H24O6 (300.1573)

Maybridge3_002474

C16H20N4O2 (300.1586)

MCULE-8866565693

C19H24OS (300.1548)

MCULE-4814254518

C15H24O6 (300.1573)

Spicifernin

C15H24O6 (300.1573)

(2Z,4E)-3-methyl-5-(1,2,4-trihydroxy-2-hydroxymethyl-6,6-dimethylcyclohexyl)penta-2,4-dienoic acid|monaspilosuslin

C15H24O6 (300.1573)

debenzoyl-7-deoxo-1alpha,7alpha-dihydroxytashironin

C15H24O6 (300.1573)

C15H24O6

C15H24O6 (300.1573)

Secosyrin 2

C15H24O6 (300.1573)

(+)-syributin 2|Syributin 2

C15H24O6 (300.1573)

1,6-Dihydroxy-3-deoxyminwanensin

C15H24O6 (300.1573)

arecoic acid A

C15H24O6 (300.1573)

frehmaglutin A

C15H24O6 (300.1573)

deschloro 12-epi-fischerindole W nitrile

C21H20N2 (300.1626)

3,5-Dihydroxy-5-heptyl-2,3,3a,5,5a,8-hexahydro-6H-1,4,7-trioxacyclopenta[c]pentalene-6-one

C15H24O6 (300.1573)

7-deoxy-7beta-hydroxypseudoanisatin

C15H24O6 (300.1573)

8-Deoxymerrilliortholactone

C15H24O6 (300.1573)

Hydroxylupanine HCl

C15H25ClN2O2 (300.1604)

Tetracaine hydrochloride

C15H25ClN2O2 (300.1604)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1573)

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1573)

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol_major

C15H24O6 (300.1573)

IU1

C18H21FN2O (300.1638)

Zinndiol: 1-[4,5-Bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methyl-2,3-butanediol

C15H24O6 (300.1573)

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enoic acid

C15H24O6 (300.1573)

2-Hydroxymethyl-piperazine-1,4-dicarboxylic acid 4-allyl ester 1-tert-butyl ester

C14H24N2O5 (300.1685)

[2-(2-methyl-3-nitro-phenyl)-ethyl]-dipropyl-amine hydrochloride

C15H25ClN2O2 (300.1604)

3-[1,1-Biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthol

C22H20O (300.1514)

3-PHENYL-1-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[C]PYRIDINE

C21H20N2 (300.1626)

4-(4-phenylphenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

C21H20N2 (300.1626)

poly(ethylene-co-acrylic acid)

C15H24O6 (300.1573)

Pirbuterol Acetate

C14H24N2O5 (300.1685)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

2,4,5-triphenylimidazolidine

C21H20N2 (300.1626)

4-ACETYLAMINO-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXOAMMONIUM TETRAFLUOROBORATE

C11H21BF4N2O2- (300.1632)

Tri(propylene glycol) diacrylate

C15H24O6 (300.1573)

2,2-[[4-[(4-aminophenyl)azo]phenyl]imino]bisethanol

C16H20N4O2 (300.1586)

disperse black 9

C16H20N4O2 (300.1586)

Itasetron

C16H20N4O2 (300.1586)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

1-(4-Hydroxyphenyl)-1,2-diphenyl-1-butene

C22H20O (300.1514)

3-Amino-4-{3-[2-(2-propoxy-ethoxy)-ethoxy]-propylamino}-cyclobut-3-ene-1,2-dione

C14H24N2O5 (300.1685)

Azapropazone

C16H20N4O2 (300.1586)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

(R)-N-methylcoclaurinium

C18H22NO3+ (300.16)

(S)-N-methylcoclaurinium(1+)

C18H22NO3+ (300.16)

The conjugate acid of (S)-N-methylcoclaurine; major species at pH 7.3.

Codeine(1+)

C18H22NO3+ (300.16)

The conjugate acid of codeine arising from protonation of the tertiary amino group; major species at pH 7.3.

diacetyl-lys-D-ala

C13H22N3O5- (300.1559)

5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-propylpentanehydrazide

C13H24N4O2S (300.162)

5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine

C16H20N4O2 (300.1586)

6-De(cyclopropylamino)-6-(2-methylazetidin-1-yl)abacavir

C15H20N6O (300.1699)

(5R,8R)-8-methyl-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C16H20N4O2 (300.1586)

(7S)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.1586)

(4R,7S)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.1586)

(4R,7R)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.1586)

(5S)-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C16H20N4O2 (300.1586)

(7R)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.1586)

Neopine cation

C18H22NO3+ (300.16)

Benzaldehyde, bis(phenylmethyl)hydrazone

C21H20N2 (300.1626)

2-[Hydroxy-(2-hydroxy-3-propoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C11H27NO6P+ (300.1576)

neopine(1+)

C18H22NO3 (300.16)

An ammonium ion derivative that is the conjugate acid of neopine arising from protonation of the tertiary amino group; major species at pH 7.3.

BIA 10-2474

C16H20N4O2 (300.1586)

BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.

(3as,5r,5as,7r,8s,9r,9as,9br)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1573)

(3r,4s,5r)-3-hydroxy-8-oxo-1,7-dioxaspiro[4.4]nonan-4-yl octanoate

C15H24O6 (300.1573)

1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

C15H24O6 (300.1573)

(1r,3r,4r,5r,6r,7s,11r)-3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

C15H24O6 (300.1573)

ethyl (2r)-2,5-bis[(2s)-butan-2-yl]-3-hydroxy-6-oxo-1,3,4-oxadiazine-2-carboxylate

C14H24N2O5 (300.1685)

(2r,3r)-2,3-dihydroxy-3-(5-oxo-2h-furan-3-yl)propyl octanoate

C15H24O6 (300.1573)

(1r,2s)-2-ethenyl-2,6-dimethyl-1h,3h,4h,7h-cyclohexa[c]carbazole-1-carbonitrile

C21H20N2 (300.1626)

n'-{5-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]naphthalen-1-yl}-n,n-dimethylcarbamimidic acid

C16H20N4O2 (300.1586)

(1s,2r,5r,6s,8r,10s,13r,14r)-1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

C15H24O6 (300.1573)

(2s)-1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1573)

(1s,4as,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1573)

(1r,2r,4s,5r,6r,12r,13r)-4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

C15H24O6 (300.1573)

(1r,2s,5r,6s,7s,8r,11r)-11-[(2r)-1,2-dihydroxypropan-2-yl]-7-hydroxy-5-(hydroxymethyl)-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecan-10-one

C15H24O6 (300.1573)

7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

C15H24O6 (300.1573)

(3ar,5s,5ar,7s,8r,9s,9ar,9bs)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1573)

ethyl (6r)-3,6-bis[(2s)-butan-2-yl]-5-hydroxy-4-oxo-1,2,5-oxadiazine-6-carboxylate

C14H24N2O5 (300.1685)

(2s)-4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

C15H24O6 (300.1573)

(1r,2r,4s,5r,6r,7r,8r)-4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

C15H24O6 (300.1573)

(1s,4ar,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1573)

4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

C15H24O6 (300.1573)

5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1573)

2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

C15H24O6 (300.1573)

4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

C15H24O6 (300.1573)

ethyl (6s)-3,6-bis[(2s)-butan-2-yl]-5-hydroxy-4-oxo-1,2,5-oxadiazine-6-carboxylate

C14H24N2O5 (300.1685)

6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1573)

3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

C15H24O6 (300.1573)

{4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,4,7-tetraen-6-ylidene}(methyl)oxidanium

[C18H22NO3]+ (300.16)

(1r,4r,5s,7r,8s)-7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

C15H24O6 (300.1573)

2-ethenyl-2,6-dimethyl-1h,3h,4h,7h-cyclohexa[c]carbazole-1-carbonitrile

C21H20N2 (300.1626)

ethyl (2s)-2,5-bis[(2s)-butan-2-yl]-3-hydroxy-6-oxo-1,3,4-oxadiazine-2-carboxylate

C14H24N2O5 (300.1685)

4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

C15H24O6 (300.1573)

ethyl 3-hydroxy-6-oxo-2,5-bis(sec-butyl)-1,3,4-oxadiazine-2-carboxylate

C14H24N2O5 (300.1685)

ethyl 5-hydroxy-4-oxo-3,6-bis(sec-butyl)-1,2,5-oxadiazine-6-carboxylate

C14H24N2O5 (300.1685)

(1r,2s,5s,6s,9s,10s,11s,13r)-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

C15H24O6 (300.1573)

(1r,2s,6r,7r,8s,9r,11s,12r)-1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

C15H24O6 (300.1573)

1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

C15H24O6 (300.1573)